Extra-aortic identifiers to guide genetic testing in familial thoracic aortic aneurysms and dissections syndromes: It is all about the company one keeps

Journal of the American College of Cardiology

Volumn 60, Issue 5, 2012, Pages 404-407

  Arbustini, Eloisa ^a   Narula, Nupoor ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

aneurysm; aorta; cerebrovascular disorders; genetics; SMAD3

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ACTA2 GENE; ANEURYSM; ANEURYSM OSTEOARTHRITIS SYNDROME; AORTA ANEURYSM; AORTA DISSECTION; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; FAMILIAL DISEASE; FAMILIAL THORACIC AORTIC ANEURYSM AND DISSECTION; GENE; GENE FUNCTION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SCREENING; GENETIC TRAIT; HUMAN; MARFAN SYNDROME; MUTATIONAL ANALYSIS; MYH11 GENE; MYLK GENE; NOTE; OSTEOARTHRITIS; PATENT DUCTUS ARTERIOSUS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMAD3 GENE; SMAD4 GENE; TGF BETA1 GENE; TGFBR1 GENE; TGFBR2 GENE;

EID: 84864279482     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.032     Document Type: Editorial

References (23)

1. H. Pannu, V.T. Fadulu, J. Chang Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections Circulation 112 2005 513 520 (Pubitemid 41060791)
2. L. Zhu, R. Vranckx, P.K. Van Kien Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus Nat Genet 38 2006 343 349
3. M. Renard, B. Callewaert, M. Baetens Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD Int J Cardiol 2011 Sep 19 [E-pub ahead of print]
4. D.C. Guo, H. Pannu, V. Tran-Fadulu Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections Nat Genet 39 2007 1488 1493 (Pubitemid 350191352)
5. D.M. Milewicz, J.R. Ostergaard, R.M. Ala-Kokko De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction Am J Med Genet A 152A 2010 2437 2443
6. E. Disabella, M. Grasso, F.I. Gambarin Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2) Heart 97 2011 321 326
7. L. Wang, D.C. Guo, J. Cao Mutations in myosin light chain kinase cause familial aortic dissections Am J Hum Genet 87 2010 701 707
8. I.M.B.H. van de Laar, R.A. Oldenburg, G. Pals Mutations in SMAD3 cause a syndrome form of aortic aneurysms and dissections with early-onset osteoarthritis Nat Genet 43 2011 121 126
9. E.S. Regalado, D. Guo, C. Villamizar Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms Circ Res 109 2011 680 686
10. E. Regalado, S. Medrek, V. Tran-Fadulu Autosomal dominant inheritance of a predisposition to thoracic aortic aneurysms and dissections and intracranial saccular aneurysms Am J Med Genet 155A 2011 2125 2130
11. S. Andrabi, M.R. Bekheirnia, P. Robbins-Furman, R.A. Lewis, T.W. Prior, L. Potocki SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction Am J Med Genet A 155A 2011 1165 1169
12. C. VanHemelrijk, M. Renard, B. Loeys The Loeys-Dietz syndrome: an update for the clinician Curr Opin Cardiol 25 2010 546 551
13. B.L. Loeys, H.C. Dietz, A.C. Braverman The revised Ghent nosology for the Marfan syndrome J Med Genet 47 2010 476 485
14. L. Faivre, G. Collod-Beroud, L. Adès The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet 81 2012 433 442
15. B.S. Brooke, J.P. Habashi, D.P. Judge, N. Patel, B. Loeys, H.C. Dietz 3rd Angiotensin II blockade and aortic-root dilation in Marfan's syndrome N Engl J Med 358 2008 2787 2795 (Pubitemid 351930853)
16. R.V. Lacro, H.C. Dietz, L.M. Wruck Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome Am Heart J 154 2007 624 631 (Pubitemid 47429596)
17. F.I. Gambarin, V. Favalli, A. Serio Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations J Cardiovasc Med 10 2009 354 362
18. J.P. Habashi, D.P. Judge, T.M. Holm Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome Science 312 2006 117 121
19. D. van der Linde, I.M.B.H. van de Laar, A.M. Bertoli-Avella Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants J Am Coll Cardiol 60 2012 397 403
20. I.M. van de Laar, D. van der Linde, E.H. Oei Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome Med Genet 49 2012 47 57
21. L. Attisano, J.L. Wrana Signal transduction by the TGF-beta superfamily Science 296 2002 1646 1647
22. L.F. Hiratzka, G.L. Bakris, J.A. Beckman 2010 ACCF/AHA/AATS/ACR/ASA/SCA/ SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine J Am Coll Cardiol 55 2010 e27 e129
23. N.D. Patel, G.J. Arnaoutakis, T.J. George Valve-sparing aortic root replacement in Loeys-Dietz syndrome Ann Thorac Surg 92 2011 556 560